Private label or white label: exclusivity, specification and who owns the recipe

Comparison criteria

Criteria are stated explicitly and neither option is declared a winner: which one fits depends on the constraint that binds hardest in your operation.

Exclusivity is a clause, not a physical property

Nothing about a dedicated production run stops a maker offering a near-identical article to someone else, and plenty do. Exclusivity exists only where the agreement creates it, and the useful version names what is protected — the formulation, the tooling, the pack format, a defined territory — and for how long, with a volume commitment attached so the maker is not asked to hold capacity for nothing. Ask what happens if you miss that commitment, because the usual answer is that exclusivity lapses quietly. Ask too whether the maker may sell a variant with a single ingredient changed, which is the standard route around a poorly drafted restriction.

Artwork and the product file are separate deliverables

Brand owners tend to focus on the pack because that is the visible part, and then discover that the substantiation behind the pack lives somewhere else entirely. Specification sheets, ingredient or component declarations, test reports, shelf-life or endurance data and batch records form a file that someone must be able to produce when a retailer, a customer or an authority asks. Decide at contract stage who compiles it, who holds the original, whether copies come to you as a matter of course, and what you receive if the relationship ends. A brand that owns artwork but not evidence is a brand that cannot change supplier without redoing the work.

Category rules decide how far the label can travel from the maker

In regulated categories the party named on the pack usually carries duties that cannot be contracted away, whatever the commercial arrangement behind it. That has practical consequences: you may need a named responsible person, a retrievable batch record, a route to recall product from the trade, and someone able to answer a technical question without a week of correspondence. This weighs on the choice in both directions. Buying an existing article gives you less to compile but also less control over answers; commissioning your own means the file is yours to build, and yours to keep current every time the specification moves.

Frequently asked questions

Can a white-label product be made exclusive later?

Sometimes, and it is a normal way to graduate a relationship. The route is usually a commitment on your side — a volume undertaking or a defined term — in exchange for a restriction on the maker's side covering a named market or channel. What rarely survives negotiation is exclusivity over an article the maker already sells widely, because existing customers have a claim on it. The workable version is exclusivity over a modified version created for you, which puts you into a private-label arrangement in all but name.

Who is responsible if a labelled product turns out to be defective?

The party whose brand appears on the pack is generally the one a customer, a retailer and an authority approach first, regardless of who mixed or assembled it. Recovery against the maker then depends entirely on the supply agreement: what the specification said, what testing was contracted, what warranty and indemnity terms exist, and what insurance sits behind them. This is why the substantiation file and the contract deserve as much attention as the unit price, and why traceability to a batch is worth insisting on early.

Does a private-label specification stop the maker copying it?

Not by itself. A specification records what is to be made; it does not create a right that prevents someone else making something similar. Protection comes from the agreement — confidentiality, an assignment of the developed specification to you, and a restriction on selling the same or a materially similar article — supported by whatever registered rights genuinely apply to your brand and pack design. Where development is substantial, agree ownership of the result before work begins rather than after the first successful trial run.